Medical Research and GCP Training Services in Russia

UK based MNC,Helix Research Center has announced Medical Research and GCP Training Services for the Global Biopharmaceutical,Medical Device,Cosmetic companies and other R&D Promoters willing to conduct their Clinical Trials in Russia

It is an established fact the Russia is the largest Country in the World in terms of land area( extending across entire Northern Asia and 40% of Europe)and ninth populous Nation.The Healthcare Infrastructure in Russia is one of the best in the World and Health Services provided by the Government are absolutely free for any Citizen.A small percentage of the population opt for Private Healthcare invariably through Private Insurance companies.Today,Russia is one of the preferred destinations for placing Global Clinical Trials due to high patient enrollment rate,strict GCP compliance by Principal Investigators and their support staff,relatively less per Patient cost for the Sponsors,State of the art Central Labs and Sample Storage/ Transport System,International quality data and insignificant 'Findings' during Regulatory and Sponsor Audits etc.


Moreover,there has been a substantial increase in the number of Research and Development (R&D) units established by Domestic as well as Multinational companies in Russia in the recent past and many more Pharma,Biotech,Device companies are exploring the possibility of setting R&D and Manufacturing Units.Russia can also emerge as Most Favored country for setting up Pre Clinical,Bio Analytical, Bio Availability and Bio Equivalence Facilities in the existing Academic Institutions and Hospitals which are Huge structures.If the Russian Government takes the initiative to propagate their Healthcare Potential,Medical Tourism can emerge as one of their revenue generating sector.Russia has a large pool of Doctors(Clinical Research Investigators) belonging to various Therapeutic areas,Qualified Nursing staff and enthusiastic Life Sciences candidates to work as Clinical Research Associates,Study Coordinators etc.


Helix Research Center will be launching entire spectrum Clinical Research Services ,with a main focus on Phase 0 through IV Clinical Trial and Monitoring Services in major Therapeutic areas such as Oncology,Cardiology,Endocrinology,Dermatology,Urology,Nephrology,Gastroenterology,Pulmonology,ENT,OBG,Opthalmology etc.Since the 'Eyes can not see if the Mind does not know',providing GCP ( Good Clinical Practices) Training for Research Teams will be another major activity.

Helix Research Center firmly believes in Ergonomics,Symbiosis,Co operation,Collaboration and keeps away from 'Competition' and 'Conflict of Interest'.In view of Second 'Recession ' round the corner,which is most likely to be more severe than the previous one,there is a dire need for all the enterprises to embrace 'Neo Barter System'; that is exchange the capabilities inroder to reduce the avoidable expenditures and thereby survive the Global Economic slowdown.New Drug Discovery and Healthcare are most Essential Services, inroder to diagnose and treat many fatal diseases that are prevalent in the World Community, responsible for high morbidity and mortality every year.Hence,Helix is always open to working with like minded Groups,Institutions,Associations etc so as to contribute its share to promote R&D and Healthcare.